About Ignota Labs
Ignota Labs is a multi-award-winning drug turnaround company tackling one of the industry’s biggest bottlenecks: drug safety. Through cutting-edge explainable AI, we identify and resolve toxicity issues in promising drug candidates, unlocking their potential to become safe, effective therapies.
Join Cambridge Network for a half-day workshop to explore how organisations can move from neurodiversity awareness to embedding it in their everyday strategy and practices. Designed for leaders, managers, and HR professionals, this event will explore how neuro‑inclusion can be built into culture, operations and decision‑making in a way that creates meaningful and lasting impact.
Amsbio offers a comprehensive range of pre-made lentiviral particles for delivering target genes into most types of dividing and non-dividing mammalian cells in vitro and in vivo.
Lentiviral particles provide long-term, stable expression of genes, making them ideal for stable cell line engineering, CRISPR applications, and therapeutic gene transfer.
About us
The Francis Crick Institute is Europe’s largest biomedical research institute under one roof. Our world-class scientists and staff collaborate on vital research to help prevent, diagnose and treat illnesses such as cancer, heart disease, infectious diseases and neurodegenerative conditions.
About us
The Babraham Research Campus is considered to be the UK’s leading campus to support early-stage bioscience enterprises. World class research and business come together to promote innovation and strengthen links between academia and the commercial world.
The pioneering purpose-built life science facility opens in March 2026
Glasgow, February, 2026
Located within the Glasgow Riverside Innovation District (GRID), the highly anticipated Health Innovation Hub (HiH) has secured Panthera as a new tenant ahead of its official opening next month. The announcement further strengthens the Hub’s growing community of healthcare innovators and highlights its role in supporting collaboration, growth and clinical excellence.
LONDON, UK and COPENHAGEN, Denmark – February 24, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led the search for Hans T. Schambye, MD, PhD for his appointment to the Board of Directors at BOOST Pharma (“BOOST”), and is now pleased to announce his transition to Chief Executive Officer (CEO).
Join us at CamNTF for a day of discussing cutting-edge therapeutics in Cambridge!
Join us for an insightful in-person event hosted by the Cambridge Alliance on Medicines Safety (CAMS) and the British Toxicology Society (BTS) at the Jeffrey Cheah Biomedical Centre, focused on the safety of advanced therapeutics.
We’re looking for an experienced Qualified Person (QP) to provide QP certification, quality leadership, and compliance oversight across Crinone® commercial operations. You’ll ensure batches are released in line with UK legislation, cGMP, and the Orange Guide, while supporting projects, audits, and continuous improvement across the business.
The Role: